Here is a new possible therapy for you to gain weight.
Pediatric Pulmonology
Volume 38, Issue 2 , Pages 129 - 134Published Online: 14 May 2004Copyright © 2004 Wiley-Liss, Inc., A Wiley Company
Cyproheptadine is an effective appetite stimulant in cystic fibrosis
Douglas N. Homnick, MD, MPH 1 *, Benjamin D. Homnick 2, Andrew J. Reeves, RPh 1, John H. Marks, MD 1, Ronald S. Pimentel, MS 3, Sally K. Bonnema, RD, MA 4
1Division of Pediatric Pulmonology, Department of Pediatrics, Kalamazoo Center for Medical Studies, Michigan State University, Kalamazoo, Michigan
2Kalamazoo Area Mathematics and Science Center, Kalamazoo, Michigan
3Department of Statistics, Western Michigan University, Kalamazoo, Michigan
4Department of Nutrition, Bronson Hospital, Kalamazoo, Michigan
email: Douglas N. Homnick (Homnick@kcms.msu.edu)
*Correspondence to Douglas N. Homnick, Division of Pediatric Pulmonology, Department of Pediatrics, Kalamazoo Center for Medical Studies, Michigan State University, 1000 Oakland Drive, Kalamazoo, MI 49008.Presented at the 17th Annual North American Cystic Fibrosis Conference, Anaheim, California, October 6-19, 2003.
setDOI("ADOI=10.1002/ppul.20043")Funded by:
MSU/KCMS CF Center Grant
Bronson Community Research FundKeywords
cyproheptadine • antihistamines • appetite stimulants • cystic fibrosis
Abstract
Chronic pulmonary infection and intestinal malabsorption often lead to malnutrition in children and adults with cystic fibrosis (CF). Appetite stimulants, along with provision of adequate calories, may aid in overcoming nutritional deficits, allowing a better prognosis. We undertook a trial of cyproheptadine hydrochloride (CH) to determine its effectiveness as an appetite stimulant in 18 adults and children with CF. This was a 12-week, randomized, double-blind, controlled trial of CH vs. placebo. Eighteen subjects with documented CF (sweat or genetics positive), minimum age of 5 years, and ideal body weight for height <100% were entered, and 16 completed the study. Subjects were seen at baseline and every 4 weeks. Measures included baseline demographics, Shwachman score, anthropometrics (weight, height, body mass index, skin folds, and body composition by bioelectric impedance analysis), spirometry, caloric intake, days of oral (PO) and intravenous (IV) antibiotics, and a symptom and satisfaction survey. Subjects in the CH group showed significant increases in weight (mean 3.45 kg vs. 1.1 kg in the placebo group), height, BMI percentiles, ideal body weight/height, weight for age z-scores, and fat and fat-free mass. There were no changes or differences in PO or IV antibiotic use or spirometric changes. No significant side effects except transient mild sedation occurred in the CH group. Patient acceptance was good. In conclusion, CH appears to be an effective appetite stimulant with minimal side effects in children and adults with CF. Pediatr Pulmonol. © 2004 Wiley-Liss, Inc.
Received: 21 October 2003; Revised: 16 January 2004; Accepted: 17 January 2004Digital Object Identifier (DOI)
Joanne M. Schum
Cystic Fibrosis
Bi-lateral Lung Transplant Recipient
September 12, 1997
University of North Carolina Hospitals Chapel Hill
Residence: Upstate New York
email: luckylungsforjo@aol.com
Manager of: Transplant Support - Lung, Heart/Lung, Heart
http://groups.msn.com/TransplantSupportLungHeartLungHeart
"Taking Flight - Inspirational Stories of Lung Transplantation"
Compiled by Joanne Schum
Authored by lung recipients around the world
http://www.trafford.com/robots/02-0497.html
http://www.trafford.com/
Lungs for Life Foundation
http://www.lungsforlife.org
Joanne's Bracelet, Transplant Awareness Bracelet, CF Awareness Bracelet
http://www.lungsforlife.org/other_ways/lfl_store.htm